{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:33:08Z","timestamp":1648780388504},"reference-count":36,"publisher":"Japan Society for Clinical Immunology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2012]]},"DOI":"10.2177\/jsci.35.520","type":"journal-article","created":{"date-parts":[[2012,12,30]],"date-time":"2012-12-30T22:33:06Z","timestamp":1356906786000},"page":"520-525","source":"Crossref","is-referenced-by-count":1,"title":["Psoriasiform eruption induced by adalimumab in a patient with rheumatoid arthritis : a case report and review of literature"],"prefix":"10.2177","volume":"35","author":[{"given":"Haruna","family":"KUNO","sequence":"first","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"KOTANI","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"TAKEUCHI","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"WAKURA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"WAKURA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitoshi","family":"YU","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeki","family":"MAKINO","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"MORIWAKI","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"HANAFUSA","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine (I), Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1"},{"key":"2","unstructured":"2) Grinblat, B., Scheinberg, M. : The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy : a review. Semin Arthritis Rheum<\/i>. 37<\/b> : 251-255, 2008."},{"key":"3","unstructured":"3) Beuthien, W., et al. : Skin reaction to adalimumab. Arthritis Rheum<\/i>. 50<\/b> : 1690-1692, 2004."},{"key":"4","unstructured":"4) Kary, S., et al. : New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. Ann Rheum Dis<\/i>. 65<\/b> : 405-407, 2006."},{"key":"5","unstructured":"5) Sfikakis, P.P., et al. : Psoriasis induced by anti-tumor necrosis factor therapy : a paradoxical adverse reaction. Arthritis Rheum<\/i>. 52<\/b> : 2513-2518, 2005."},{"key":"6","unstructured":"6) Michaëlsson, G., et al. : The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J Am Acad Dermatol<\/i>. 54<\/b> : 737-738, 2006."},{"key":"7","unstructured":"7) Flendrie, M., et al. : Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis : a prospective study. Arthritis Res Ther<\/i>. 7<\/b> : R666-676, 2005."},{"key":"8","unstructured":"8) Dereure, O., et al. : Psoriatic lesions induced by antitumour necrosis factor-alpha treatment : two cases. Br J Dermatol<\/i>. 151<\/b> : 506-507, 2004."},{"key":"9","unstructured":"9) Sari, I., et al. : Anti-tumor necrosis factor-alpha-induced psoriasis. J Rheumatol<\/i>. 33<\/b> : 1411-1414, 2006."},{"key":"10","unstructured":"10) Pirard, D., et al. : Anti-tumor necrosis factor alpha-induced psoriasiform eruptions : three further cases and current overview. Dermatology<\/i>. 213<\/b> : 182-186, 2006."},{"key":"11","unstructured":"11) Cohen, A.D., et al. : Drug exposure and psoriasis vulgaris : case-control and case-crossover studies. Acta Derm Venereol<\/i>. 85<\/b> : 299-303, 2005."},{"key":"12","unstructured":"12) Goncalves, D.P., et al. : The appearance of pustular psoriasis during antitumor necrosis factor therapy. J Clin Rheumatol<\/i>. 12<\/b> : 262, 2006."},{"key":"13","unstructured":"13) Matthews, C., et al. : Development of new-onset psoriasis while on anti-TNFalpha treatment. Ann Rheum Dis<\/i>. 65<\/b> : 1529-1530, 2006."},{"key":"14","unstructured":"14) Roux, C.H., et al. : New-onset psoriatic palmoplantaris pustulosis following infliximab therapy : a class effect? J Rheumatol<\/i>. 34<\/b> : 434-437, 2007."},{"key":"15","unstructured":"15) Richette, P., et al. : Psoriasis induced by anti-tumor necrosis factor therapy : a class effect? J Rheumatol<\/i>. 34<\/b> : 438-439, 2007."},{"key":"16","unstructured":"16) Jarrett, A. : Treatment of psoriasis with vitamin A. Br J Dermatol<\/i>. 88<\/b> : 309-310, 1973."},{"key":"17","unstructured":"17) Starmans-Kool, M.J., et al. : Pustular skin lesions in patients treated with infliximab : report of two cases. Rheumatol Int<\/i>. 25<\/b> : 550-552, 2005."},{"key":"18","unstructured":"18) Zarinitsky, C., et al. : Pustulose palmaire et plantaire chez une patiente traitee par adalimumab. RevRhum<\/i>. 72<\/b> : 1195, 2005."},{"key":"19","unstructured":"19) Solau-Gervais, E., et al. : Lack of efficacy of a third tumour necrosis factor alpha antagonist after failure of a soluble receptor and a monoclonal antibody. Rheumatology (Oxford)<\/i>. 45<\/b> : 1121-1124, 2006."},{"key":"20","unstructured":"20) Aslanidis, S., et al. : Anti-TNF-alpha-induced psoriasis : case report of an unusual adverse event. Int J Dermatol<\/i>. 45<\/b> : 982-983, 2006."},{"key":"21","unstructured":"21) Goiriz, R., et al. : Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers. Clin Exp Dermatol<\/i>. 32<\/b> : 176-179, 2007."},{"key":"22","unstructured":"22) Volpe, A., et al. : Psoriasis onset during infliximab treatment : description of two cases. Rheumatol Int<\/i>. 26<\/b> : 1158-1160, 2006."},{"key":"23","unstructured":"23) Ubriani, R., Van Voorhees, A.S. : Onset of psoriasis during treatment with TNF-α antagonists : a report of 3 cases. Arch Dermatol<\/i>. 143<\/b> : 270-272, 2007."},{"key":"24","unstructured":"24) Lebas, D., et al. : Cutaneous manifestations during treatment with TNF-alpha blockers : 11 cases. Ann Dermatol Venereol<\/i>. 134<\/b> : 337-342, 2007."},{"key":"25","unstructured":"25) de Gannes, G.C., et al. : Psoriasis and pustular dermatitis triggered by TNF-α inhibitors in patients with rheumatologic conditions. Arch Dermatol<\/i>. 143<\/b> : 223-231, 2007."},{"key":"26","unstructured":"26) Seneschal, J., et al. : Psoriasiform drug eruptions under anti-TNF treatment of arthritis are not true psoriasis. Acta Derm Venereol<\/i>. 87<\/b> : 77-80, 2007."},{"key":"27","unstructured":"27) Wollina, U., et al. : Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata : first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol<\/i>. 9<\/b> : 1-14, 2008."},{"key":"28","unstructured":"28) Laga, AC., et al. : Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies. Am J Dermatopathol<\/i>. 32<\/b> : 568-573, 2010."},{"key":"29","unstructured":"29) Cuchacovich, R., et al. : Biologic therapy (TNF-alpha antagonists)-induced psoriasis : a cytokine imbalance between TNF-alpha and IFN-alpha? J Clin Rheumatol<\/i>. 14<\/b> : 353-356, 2008."},{"key":"30","unstructured":"30) Carter, J.D., et al. : Psoriasiform lesions induced by tumour necrosis factor antagonists : a skin-deep medical conundrum. Ann Rheum Dis<\/i>. 67<\/b> : 1181-1183, 2008."},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1995.0029"},{"key":"32","unstructured":"34) Ritchlin, C., Tausk, F. : A medical conundrum : onset of psoriasis in patients receiving antitumour necrosis factor agents. Ann Rheum Dis<\/i>. 65<\/b> : 1541-1544, 2006."},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.120568"},{"key":"34","unstructured":"36) Collamer, A.N., et al. : Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy : a literature review and potential mechanisms of action. Arthritis Rheum<\/i>. 59<\/b> : 996-1001, 2008."},{"key":"35","unstructured":"37) Sibilia, J., Westhovens, R. : Safety of T-cell co-stimulation modulation with abatacept in patients with rheumatoid arthritis. Clin Exp Rheumatol<\/i>. 25<\/b> : S46-56, 2007."},{"key":"36","unstructured":"38) Wendling, D., et al. : Psoriasis onset with tocilizumab treatment for rheumatoid arthritis. J Rheumatol<\/i>. 39<\/b> : 657, 2012."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/35\/6\/35_520\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:51:28Z","timestamp":1621486288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/35\/6\/35_520\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.35.520","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}